The global laboratory information systems market was is valued at $1.8bn in 2017 and is expected to grow at a CAGR of 8.3% from 2018 to 2028. In 2017, the software segment held 71% of the global laboratory information systems market.
How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector.
By ordering and reading our brand-new report today you stay better informed and ready to act.
Report Scope
• Global Laboratory Information Systems Market outlook from 2018-2028
• Global Laboratory Information Systems Submarkets analysis and forecast from 2018-2028, by delivery: • Web-based • On-Premise based • Cloud-based
• Global Laboratory Information Systems Submarkets analysis and forecast from 2018-2028, by application: • Clinical • Drug Discovery • Industrial
• Global Laboratory Information Systems Submarkets analysis and forecast from 2018-2028, by component: • Software • Hardware • Services
• This report provides individual revenue forecasts from 2018-2028 for these regional and national markets: • North America: US, Canada, Mexico • Europe: UK, Germany, France, Rest of Europe • Asia-Pacific: Japan, China, India, Rest of Asia-Pacific • Rest of the World (RoW)
• Our study discusses the selected leading companies that are the major players in the laboratory information systems market: • Abbott Laboratories • Cerner Corporation • Eclipsys Corporation • LabVantage Solutions, Inc. • LabWare, Inc. • McKesson Corporation • Medical Information Technology, Inc. • Thermo Fisher Scientific
• This report provides a Porter’s Five Forces Analysis of the global laboratory information systems market.
Visiongain’s study is intended for anyone requiring commercial analyses for the biologics market. You find data, trends and predictions.
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
Win a Free Visiongain Pharma report – ‘Like’ our Pharma Facebook page with the link below and enter into our raffle to win a free, unlocked Visiongain report, choosing your relevant report from our reports selection.
Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.
Visiongain Publishes Drug Delivery Technologies Market Report 2021-2031
Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand for advanced drug delivery technologies for chronic treatment are some of the major factors that drive the growth of the global drug delivery technologies market.
Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their customers’ operations and gaining the maximum share of their outsourcing budgets, driven by the willingness of pharma to reduce the number of outsourcers they use.
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
